Monges Viviane
SEC insider (Form 3/4/5 filer). CIK 0001838204. Director at Pharvaris N.V. (PHVS) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in LEXINGTON, MA.
Companies Monges Viviane has filed insider reports for
- Pharvaris N.V. (PHVS): Director
- ADC Therapeutics SA (ADCT): Director
Monges Viviane
CIK: 0001838204
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (28.6%)
Position reduction
Option Exercises (M)1 (14.3%)
Derivative conversions
Awards (A)2 (28.6%)
Compensation grants
Other (G, F, J, C, D, …)2 (28.6%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 23, 2026PHVS
Pharvaris N.V.
SaleDirect12K shares at avg. $33.05$396K - Sep 23, 2026PHVS
Pharvaris N.V.
ExerciseDirect12K shares at avg. $8.05$96K - Jun 3, 2026ADCT
ADC Therapeutics SA
Tax PaymentDirect2.6K shares at avg. $3.08$8K - Jun 1, 2026ADCT
ADC Therapeutics SA
AwardDirect45K shares- - May 21, 2026PHVS
Pharvaris N.V.
SaleDirect9.7K shares at avg. $30.29$293K - Jun 13, 2025ADCT
ADC Therapeutics SA
Tax PaymentDirect2.6K shares at avg. $3.58$9K - Jun 3, 2025ADCT
ADC Therapeutics SA
AwardDirect40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  PHVS Pharvaris N.V. | Sale | 11,969 | $33.05 | $395,524 | Direct |
| Sep 23, 2026 | PHVS Pharvaris N.V. | Exercise | 11,969 | $8.05 | $96,350 | Direct |
| Jun 3, 2026 |  ADCT ADC Therapeutics SA | Tax Payment | 2,596 | $3.08 | $7,996 | Direct |
| Jun 1, 2026 | ADCT ADC Therapeutics SA | Award | 45,000 | - | $0 | Direct |
| May 21, 2026 | PHVS Pharvaris N.V. | Sale | 9,667 | $30.29 | $292,853 | Direct |
| Jun 13, 2025 | ADCT ADC Therapeutics SA | Tax Payment | 2,584 | $3.58 | $9,251 | Direct |
| Jun 3, 2025 | ADCT ADC Therapeutics SA | Award | 40,000 | - | - | Direct |
1-7 of 7 transactions